In vivo anti-tumor activity of synthetic ether lipids is not enhanced by pharmacological modulation of tumor lipid composition

Int J Cancer. 1994 Nov 15;59(4):580-1. doi: 10.1002/ijc.2910590423.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Membrane / drug effects
  • Cholesterol / analysis
  • Drug Combinations
  • Female
  • Glycerides / pharmacology
  • Glycerides / therapeutic use
  • Leukemia L1210 / drug therapy
  • Leukemia L1210 / metabolism
  • Lymphoma, Large B-Cell, Diffuse / chemistry
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Male
  • Membrane Fluidity / drug effects
  • Membrane Lipids / chemistry*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Ovarian Neoplasms / chemistry
  • Ovarian Neoplasms / drug therapy
  • Phosphatidylcholines / pharmacology
  • Phosphatidylcholines / therapeutic use
  • Phosphatidylethanolamines / pharmacology
  • Phosphatidylethanolamines / therapeutic use
  • Phospholipid Ethers / pharmacology*
  • Phospholipid Ethers / therapeutic use
  • Phospholipids / analysis
  • Viscosity

Substances

  • Antineoplastic Agents
  • Drug Combinations
  • Glycerides
  • Membrane Lipids
  • Phosphatidylcholines
  • Phosphatidylethanolamines
  • Phospholipid Ethers
  • Phospholipids
  • edelfosine
  • Cholesterol
  • neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination